Australia Oxygen Therapy Market Size & Outlook, 2022-2030
Related Markets
Australia oxygen therapy market highlights
- The Australia oxygen therapy market generated a revenue of USD 868.1 million in 2022 and is expected to reach USD 1,492.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, oxygen source equipment was the largest revenue generating product in 2022.
- Oxygen Delivery Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Oxygen therapy market data book summary
| Market revenue in 2022 | USD 868.1 million |
| Market revenue in 2030 | USD 1,492.7 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Oxygen source equipment |
| Fastest growing segment | Oxygen Delivery Devices |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oxygen Source Equipment, Oxygen Delivery Devices |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Inogen Inc, Smiths Group PLC, Fisher & Paykel Healthcare Corp Ltd, Koninklijke Philips NV, Allied Healthcare Products Inc, Teleflex Inc, Chart Industries Inc, Draegerwerk AG & Co KGaA, Niterra Co Ltd, Invacare, Hersill, DeVilbiss Healthcare, Tecno-Gaz |
Other key industry trends
- In terms of revenue, Australia accounted for 2.5% of the global oxygen therapy market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China oxygen therapy market is projected to lead the regional market in terms of revenue in 2030.
- Singapore is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,773.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oxygen Therapy Market Scope
Oxygen Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Tecno-Gaz | View profile | 11-50 | Sala Baganza, Emilia-Romagna, Italy, Europe | https://www.tecnogaz.com/tecnogaz/welcome.aspx |
| DeVilbiss Healthcare | View profile | 251-500 | Somerset, Pennsylvania, United States, North America | http://www.devilbisshealthcare.com/ |
| Hersill | View profile | 11-50 | Móstoles, Madrid, Spain, Europe | https://www.hersill.com |
| Invacare | View profile | 1001-5000 | Elyria, Ohio, United States, North America | https://global.invacare.com |
| Allied Healthcare Products Inc | View profile | 146 | 1720 Sublette Avenue, Saint Louis, MO, United States, 63110 | https://www.alliedhpi.com |
| Inogen Inc | View profile | 834 | 859 Ward Drive, Goleta, CA, United States, 93111 | https://www.inogen.com |
| Draegerwerk AG & Co KGaA | View profile | 16476 | Moislinger Allee 53–55, Lubeck, Germany, 23542 | https://www.draeger.com |
| Chart Industries Inc | View profile | 11637 | 2200 Airport Industrial Drive, Suite 100, Ball Ground, GA, United States, 30107 | https://www.chartindustries.com |
| Smiths Group PLC | View profile | 15000 | 11-12 St James’s Square, 4th Floor, London, United Kingdom, SW1Y 4LB | https://www.smiths.com |
| Niterra Co Ltd | View profile | 16247 | 14-18, Takatsuji-cho, Mizuho-ku, Nagoya, Japan, 467-8525 | http://www.ngkntk.co.jp |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Fisher & Paykel Healthcare Corp Ltd | View profile | 6584 | 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, New Zealand, 2013 | https://www.fphcare.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Australia oxygen therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oxygen therapy market will help companies and investors design strategic landscapes.
Oxygen source equipment was the largest segment with a revenue share of 58.58% in 2022. Horizon Databook has segmented the Australia oxygen therapy market based on oxygen source equipment, oxygen delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing government initiatives for COPD awareness are expected to drive the overall oxygen therapy market in Australia. Many government and nongovernment organizations have started awareness programs to inform the public about COPD. For instance, to increase awareness about COPD and help patients manage the disease.
WHO and the National Heart, Lung, & Blood Institute (NHLBI) developed the global initiative for chronic obstructive lung disease. In addition, increasing expenditure in the healthcare and medical sectors by the government can be attributed to the growth of the market. Moreover, increasing number of privately owned clinics and hospitals in Australia is expected to drive growth of the market.
Reasons to subscribe to Australia oxygen therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia oxygen therapy market databook
-
Our clientele includes a mix of oxygen therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia oxygen therapy market , including forecasts for subscribers. This country databook contains high-level insights into Australia oxygen therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia oxygen therapy market size, by product, 2018-2030 (US$M)
Australia Oxygen Therapy Market Outlook Share, 2022 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
